Blood Management System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Donor Management Module, Transfusion Service Module, Inventory Management, Donation Scheduling, Screening & Testing, Reporting & Analytics, Integration & Interoperability, Others), By End User (Blood Banks, Hospitals, Ambulatory Care Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 16.32 Billion
CAGR (2026-2031)	7.57%
Fastest Growing Segment	Integration & Interoperability
Largest Market	North America
Market Size (2031)	USD 25.29 Billion

Market Overview

The Global Blood Management System Market will grow from USD 16.32 Billion in 2025 to USD 25.29 Billion by 2031 at a 7.57% CAGR. The Global Blood Management System Market encompasses the integrated software and hardware solutions designed to monitor the entire blood supply chain, including donor recruitment, collection processing, inventory oversight, and transfusion safety. The market is primarily driven by the escalating demand for blood components to treat chronic hematological diseases and the critical necessity to minimize wastage through efficient inventory control. Additionally, the rising volume of trauma cases requiring emergency transfusions compels healthcare institutions to adopt these automated workflows to ensure rapid and error-free product availability.

A significant challenge impeding market expansion is the substantial capital investment required for implementing these comprehensive digital platforms, which often strains the budgets of smaller healthcare facilities. This financial barrier is compounded by the operational complexity of managing fluctuating supplies. According to America's Blood Centers, in 2025, supply data indicated that 25 percent of monitored centers operated at critical inventory levels with one day of stock or less, underscoring the urgent necessity for the precise resource optimization that these systems provide.

Key Market Drivers

The rising global prevalence of chronic diseases and trauma cases acts as a primary catalyst for the market, creating an urgent need for systems that can efficiently mobilize and allocate scarce blood resources. As healthcare providers face mounting pressure to treat hematological disorders and emergency casualties, the disparity between donor collection and clinical demand widens. This gap is particularly acute in developing regions; according to the World Health Organization, May 2025, in the 'Blood safety and availability' update, 60 countries reported collecting fewer than 10 donations per 1,000 people, underscoring the critical need for technologies that maximize the utility of every collected unit.

Simultaneously, rapid technological advancements in automated blood management solutions reshape the sector by enhancing operational efficiency. Hospitals and blood centers are aggressively adopting integrated platforms to automate donor qualification and inventory tracking, mitigating human error and controlling costs. This shift toward digitalization is reflected in the performance of major industry players. According to Haemonetics, May 2025, in the 'Fiscal 2025 Annual Report', the company recorded a 23.7 percent revenue increase in its Hospital business, driven largely by the adoption of blood management technologies. Furthermore, the scale of the market reinforces this reliance on digital infrastructure; according to CSL Limited, in 2025, the company reported a net profit of $3.3 billion, underpinned by the sustained global demand for efficiently managed plasma therapies.

Download Free Sample Report

Key Market Challenges

The substantial capital investment required to deploy integrated blood management systems acts as a severe obstruction to market growth, particularly for smaller healthcare facilities with limited financial flexibility. These digital platforms necessitate significant upfront expenditure not only for the software and automated hardware but also for the complex integration into existing hospital information systems. For many institutions, this financial burden is prohibitive, forcing them to rely on manual or fragmented legacy methods despite the operational risks. Consequently, the adoption rate of these automated inventory oversight solutions slows significantly, as administrators are compelled to prioritize immediate clinical staffing costs over infrastructure upgrades.

This economic pressure is evidenced by the tightening profit margins across the healthcare sector, which directly reduces the disposable capital available for technological acquisition. According to the American Hospital Association, in 2025, labor costs accounted for approximately 56 percent of total hospital operating expenses, leaving a strictly limited budget for systemic improvements. This intense fiscal strain means that even though blood management systems offer efficiency gains, the initial cost barrier effectively locks a large segment of potential buyers out of the market, thereby flattening the global growth trajectory.

Key Market Trends

The integration of AI and Machine Learning for predictive inventory analytics is fundamentally reshaping how blood centers manage the delicate balance between supply shortages and product expiration. By replacing static historical averages with dynamic algorithms that account for seasonal fluctuations and trauma trends, these systems allow facilities to optimize stock levels with unprecedented precision. This shift is critical for minimizing the discard rates of short-shelf-life platelets and red blood cells while ensuring availability for emergency transfusions. The impact of this technological adoption is quantifiable. According to AABB, August 2024, in the 'AI and Data Sciences in Blood Banking' article, a hybrid computation model deployed for hospital blood banking reduced inventory levels by almost 40 percent, leading to a cost reduction of 43 percent.

The deployment of IoT-enabled smart refrigeration and cold chain monitoring is emerging as a vital trend to guarantee the physical integrity of blood products during storage and transport. Unlike traditional refrigeration, these smart systems utilize continuous remote sensors to detect temperature excursions in real-time, preventing the spoilage of sensitive plasma and biological samples. This technology also addresses sustainability goals within healthcare infrastructure by optimizing power consumption through advanced compressor regulation. According to Haier Biomedical, January 2024, in the 'Haier Biomedical Newsletter', the company's new IoT-enabled ultra-low temperature freezer technology demonstrated a 50 percent energy saving capability while ensuring precise sample viability for blood stations.

Segmental Insights

The Integration and Interoperability segment is currently experiencing the most rapid expansion within the Global Blood Management System Market due to the essential need for seamless data exchange between blood bank software and Electronic Health Records. Healthcare facilities increasingly prioritize this connectivity to minimize manual data entry errors and ensure comprehensive traceability of blood products throughout the transfusion chain. Furthermore, strict safety compliance mandates from regulatory entities, such as the US Food and Drug Administration, compel institutions to adopt centralized systems that maintain accurate real-time records. This drive for operational efficiency and patient safety directly accelerates the demand for fully interoperable solutions.

Regional Insights

North America maintains a leading position in the Global Blood Management System Market, driven by a highly developed healthcare infrastructure and a substantial volume of surgical procedures requiring reliable blood transfusions. The region’s dominance is reinforced by stringent safety protocols established by the U.S. Food and Drug Administration (FDA), which mandates rigorous tracking and quality control, thereby encouraging the adoption of automated management solutions. Furthermore, major organizations such as the American Red Cross operate extensive collection networks that rely on these systems to ensure efficiency and donor safety, solidifying the market’s expansion across the continent.

Recent Developments

• In November 2024, IT Synergistics obtained FDA 510(k) clearance for its bexWISE API, a new application programming interface designed specifically for the blood transfusion medicine sector. This software solution serves as a Class II medical device accessory, facilitating secure and efficient communication between various Blood Establishment Computer Systems and third-party applications. By enabling the seamless exchange of donor and donation-related data, the interface allows healthcare facilities to accurately determine donor eligibility and donation suitability. This regulatory clearance highlights the growing importance of interoperability and advanced data integration in modernizing blood bank operations and ensuring strict compliance with safety standards.
• In October 2024, Terumo Blood and Cell Technologies launched the Reveos Automated Blood Processing System in the United States. This innovative platform is the first device available in the U.S. market capable of automating the separation of whole blood into platelets, plasma, and red blood cell concentrates during a single centrifugation cycle. By streamlining the processing workflow and eliminating numerous manual steps, the system is designed to significantly improve operational efficiency for blood centers. The technology supports the consistent production of high-quality blood components, addressing critical supply challenges and helping healthcare staff manage heavy workloads more effectively.
• In June 2024, Grifols announced that its Procleix ArboPlex Assay was commercially available in all markets accepting the CE Mark. This diagnostic solution is the first automated nucleic acid test validated to simultaneously screen blood donors for four major arboviruses: chikungunya, dengue, West Nile, and Zika. The assay operates on the company's Procleix Panther system and is designed to enhance laboratory efficiency by consolidating the testing of multiple pathogens into a single automated run. This product launch addresses the increasing risk of arboviral outbreaks driven by climate change, providing blood centers with a robust tool to maintain transfusion safety and streamline donor screening operations.
• In March 2024, Roche received approval from the U.S. Food and Drug Administration for its cobas Malaria test for use on the cobas 6800/8800 Systems. This milestone marked the first FDA-approved molecular test intended to screen blood donors for malaria in the United States. The assay allows for the direct detection of Plasmodium RNA and DNA in whole blood samples, providing a highly sensitive alternative to existing serological and microscopic methods. This approval represents a significant advancement in safeguarding the national blood supply against potential transfusion-transmitted infections and ensures improved availability of safe blood products for patients requiring transfusions.

Key Market Players

• Cerner Corporation
• Haemonetics Corporation
• Telvent GIT S.A.
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Baxter International Inc.
• Stryker Corporation
• Becton, Dickinson and Company
• Biolife Solutions, Inc.

By Type	By End User	By Region
Donor Management Module Transfusion Service Module Inventory Management Donation Scheduling Screening & Testing Reporting & Analytics Integration & Interoperability Others	Blood Banks Hospitals Ambulatory Care Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Blood Management System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blood Management System Market, By Type:

• Donor Management Module
• Transfusion Service Module
• Inventory Management
• Donation Scheduling
• Screening & Testing
• Reporting & Analytics
• Integration & Interoperability
• Others

• Blood Management System Market, By End User:

• Blood Banks
• Hospitals
• Ambulatory Care Centers
• Others

• Blood Management System Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE